NOV Inc. (NOV) — Fair Value Analysis
Base-case fair value (P50): $24.78 · Current price: $21.03 · Verdict: Undervalued
The Verdict on NOV
NOV INC (NOV) is currently assessed as Fairly Valued based on our proprietary Monte Carlo simulations. Our analysis indicates that while the current price of $21.03 sits below the median fair value (P50) of $24.78, implying a potential +17.8%, the comprehensive assessment firmly places NOV in the "Fairly Valued" category. This verdict signifies that, across thousands of forward-looking scenarios modeled, the stock's current market valuation largely aligns with its statistically probable intrinsic worth. Investors should interpret this equilibrium as a key factor when considering new positions or managing existing ones in NOV.
How NOV stacks up against peers
NOV’s operational and financial health is categorized as average when benchmarked against its industry segment. This average quality tier provides an important context for the "Fairly Valued" verdict derived from our Monte Carlo simulations. Companies displaying an average quality tier typically trade in closer alignment with their statistically derived fair values, rather than commanding significant premiums or suffering deep discounts seen with top or bottom performers. While our simulations suggest a +17.8% towards the $24.78 from the current $21.03, this average quality profile reinforces the balanced "Fairly Valued" assessment for NOV.
What this means for investors
For investors tracking NOV, the analysis suggests that the stock at $21.03 is neither significantly overvalued nor deeply undervalued. Our Monte Carlo simulations, projecting thousands of forward scenarios, consistently point to a median fair value of $24.78, representing +17.8%. This indicates a modest potential for price appreciation towards its calculated intrinsic value. However, the overall Fairly Valued verdict means investors should anticipate price movements driven more by broader market trends or specific company news rather than a substantial valuation gap closing. For a deeper dive into the full bear case (P10) and bull case (P90) distribution, and to continuously track NOV's fair value as new fundamentals are released, sign up for a free FairCurve account.
Frequently Asked Questions
Is NOV overvalued or undervalued right now?
Based on our Monte Carlo simulations, NOV's median fair value (P50) is $24.78, while its current price stands at $21.03. This suggests NOV is currently Fairly Valued.
What is the bear case and bull case for NOV?
The full Monte Carlo distribution, including specific bear (P10) and bull (P90) price targets, along with the probability of achieving upside, is exclusively available to users who sign up for a free FairCurve account.
How does FairCurve calculate NOV's fair value?
FairCurve employs Monte Carlo simulations, running thousands of forward-looking scenarios to determine the most probable intrinsic value for NOV, considering various market and fundamental factors.
How can I track NOV's fair value as it changes?
You can add NOV to a free FairCurve watchlist to receive daily fair-value updates and instant re-valuation alerts whenever new earnings or significant company fundamentals are released.